Axogen
Axogen, Inc., headquartered in the United States, is a leading innovator in the field of regenerative medicine, specialising in peripheral nerve repair. Founded in 2002, the company has made significant strides in advancing surgical solutions for nerve injuries, with a focus on providing high-quality products that enhance patient outcomes. With a robust portfolio that includes Axoguard® Nerve Connector and Avance® Nerve Graft, Axogen stands out for its commitment to utilising human tissue for nerve repair, setting it apart from traditional synthetic alternatives. The company has established a strong market position, recognised for its pioneering contributions to nerve regeneration and repair. Operating primarily in North America, Axogen continues to expand its influence in the medical device industry, driven by a mission to restore function and improve the quality of life for patients suffering from nerve damage.
DitchCarbon Score
How does Axogen's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Axogen's score of 27 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Axogen's reported carbon emissions
In 2022, Axogen, headquartered in the US, reported total carbon emissions of approximately 1,630,000 kg CO2e. This figure includes about 526,000 kg CO2e from Scope 1 emissions and around 1,104,000 kg CO2e from Scope 2 emissions. Notably, Axogen has not disclosed any Scope 3 emissions data. Despite the significant total emissions, Axogen has not set specific reduction targets or initiatives as part of their climate commitments. The company does not currently participate in initiatives such as the Science Based Targets initiative (SBTi) or disclose any climate pledges. The emissions data is sourced directly from Axogen, Inc., and there is no indication of data being cascaded from a parent or related organization. As the company continues to operate, it may consider establishing reduction targets to align with industry standards and enhance its sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | |
|---|---|
| Scope 1 | 526,000 |
| Scope 2 | 1,104,000 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Axogen is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
